Hepatitis, Chronic Clinical Trial
Official title:
Real World Study of Chronic Viral Hepatitis
This study is aimed to collect and analyze clinical data of patients with chronic viral hepatitis in the real world, to investigate the long-term outcome of these patients and to optimize treatment options based on these data.
Chronic viral hepatitis is defined as infectious liver disease caused by persistent virus
infection for more than six months. Sustained viral replication and ongoing liver
inflammation can eventually lead to liver fibrosis/cirrhosis or even hepatocellular
carcinoma. Chronic viral hepatitis infection causes at least 80% of all liver cancers.
Though chronic viral hepatitis is a major global health concern, there is still a lack of
evidence in high quality about the management of chronic viral hepatitis and the long-term
outcome of patients. The concept of real-world data and research has been officially
introduced into China since 2010. Real-world evidence, based on real-world data, can help
practitioners have better understanding of the characteristics of the patients with different
treatment strategies.
This study is aimed to collect and analyze clinical data of patients with chronic viral
hepatitis in the real world, to investigate the long-term outcome of these patients and to
optimize treatment options based on these data.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT01005238 -
Telbivudine Versus Lamivudine for Maintenance Therapy of Patients With Chronic Hepatitis B and Negative HBV Viral Load After 6 Month of Treatment With Telbivudine
|
Phase 4 | |
| Completed |
NCT00287235 -
Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)
|
N/A | |
| Completed |
NCT02799355 -
Treatment of Chronic Hepatitis With Sofosbuvir in Combination With Ribavirin With or Without Pegylated Interferon: North India Gastroenterology Consortium
|
N/A | |
| Completed |
NCT01980290 -
Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C
|
N/A | |
| Completed |
NCT01163240 -
Epidemiological Study in Children and Adolescents With Chronic Hepatitis B
|
N/A | |
| Completed |
NCT00913757 -
A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area
|
||
| Completed |
NCT02662712 -
A Study of Orally Administered JNJ-56136379 to Evaluate Safety, Tolerability and Pharmacokinetics After Single Ascending Doses and One Multiple Dose Regimen in Healthy Participants (Part I), and After Multiple Dose Regimens in Participants With Chronic Hepatitis B (Part II)
|
Phase 1 | |
| Completed |
NCT00671671 -
Phase 1 Study To Evaluate Antiviral Activity Of Small Molecule Direct Antiviral Agent At Multiple Doses In Subjects With Chronically Infected Hepatitis C Virus.
|
Phase 1 |